"We remain focused on our three strategic priorities: driving sales growth, delivering up to 10 product approvals over the ...
Chairman Larry Ellison highlighted the AI's potential in the development of mRNA-based cancer vaccines. Read more here.
Shares of Moderna are trading higher Wednesday after Oracle Chairman Larry Ellison discussed the potential of artificial intelligence (AI) to revolutionize healthcare.
This funding, announced Friday by Moderna, builds on the $176 million it received from HHS last year to support earlier stages of vaccine research.
Plus: Moderna’s bird flu vaccine, Obamacare enrollment breaks records, and AstraZeneca’s new breast cancer treatment is FDA approved.
Investing.com -- Moderna , Inc. (NASDAQ: MRNA) shares surged 14% following remarks by Oracle (NYSE: ORCL) Chairman Larry ...
Moderna stock surged Wednesday after Oracle Chairman Larry Ellison praised the potential of artificial intelligence in ...
Key Takeaways The S&P 500 advanced 0.6% on Wednesday, Jan. 22, 2025, following the announcement of major AI investments and a ...
Now, it’s worth noting Stock Advisor’s total average return is 894% — a market-crushing outperformance compared to 176% for ...
A population-based congenital cytomegalovirus screening program in Ontario successfully screened 551,034 newborns; of those ...
At J.P. Morgan, most biopharma executives expressed a neutral stance on the incoming administration, but just days later, ...
A hearing on RFK Jr.'s appointment as HHS secretary has stalled; physicians protest his appointment and Trump has paused communications.